Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetics-directed drug discovery for combating Mycobacterium tuberculosis infection.

Journal of biomolecular structure & dynamics - 1 Feb 2017

Quan Yuan, Xiong Le, Chen Jing, Zhang Hong-Yu

Abstract excerpt

Mycobacterium tuberculosis (Mtb), the pathogen of tuberculosis (TB), is one of the most infectious bacteria in the world. The traditional strategy to combat TB involves targeting the pathogen directly; however, the rapid evolution of drug resistance lessens the efficiency of this anti-TB method. Therefore, in recent years, some researchers have turned to an alternative anti-TB strategy, which hinders Mtb...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Drug Discovery
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Bacterial

Share to Mycobacterium tuberculosis

Share to Pharmacogenomic Variants

Share to Tuberculosis

Source

Identifiers

PMID: 26900080
DOI: 10.1080/07391102.2016.1157037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetics-directed drug discovery for combating Mycobacterium tuberculosis infection.PMID 26900080Read ↗

An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable DiseasesSemantic proximity Read ↗

Intracellular Drug Targets In Mycobacterium Tuberculosis Revealed By A Chemo-Genetic ApproachSemantic proximity Read ↗

Genome analyses of 174 strains of Mycobacterium tuberculosis provide insight into the evolution of drug resistance and reveal potential drug targets.Semantic proximity Read ↗

Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Human gene expression profiling identifies key therapeutic targets in tuberculosis infection: A systematic network meta-analysis.Semantic proximity Read ↗

Integrative transcriptome-based drug repurposing in tuberculosisSemantic proximity Read ↗

Understanding the epidemiology and pathogenesis of <i>Mycobacterium tuberculosis</i> with non-redundant pangenome and population geneticsSemantic proximity Read ↗

Interaction analysis of Mycobacterium tuberculosis between host environment and highly mutated genes from population genetic structure comparisonSemantic proximity Read ↗

Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives.Semantic proximity Read ↗

Network Analysis of Human Genes Influencing Susceptibility to Mycobacterial Infections.Semantic proximity Read ↗

Bioinformatics Identification of Drug Resistance-Associated Gene Pairs in Mycobacterium tuberculosis.Semantic proximity Read ↗

Combining comparative genomic analysis with machine learning reveals some promising diagnostic markers to identify five common pathogenic non‐tuberculous mycobacteriaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.